InvestorsHub Logo
Followers 741
Posts 61427
Boards Moderated 10
Alias Born 10/05/2009

Re: None

Monday, 09/19/2022 1:21:53 PM

Monday, September 19, 2022 1:21:53 PM

Post# of 3782
$RVVTF count down has started to FDA Covid19 request for EP End Point change for the EUA application/approval.

$9/share target may be conservative if approved and or there is a buy out by BP Big Pharma.

The drug #Bucillamine has been used safely for 30 years for RA, autoimmune disease and may end up being used for what is now rampant #LongHaulCovid19

The Dales Report
@TheDalesReport
$RVVTF AGM just finished. Some key takeaways:

- Revive has 450-500 patient data scrubbed/ready to present to regulators as needed
- Capital raise possible if EP swap approved
- FDA should have EP decision in 30 days
- Clinical trial sites on standby if add-on patient data needed

Check here:

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=169985610

and Reddit and twitter for updates.

https://www.reddit.com/r/RVVTF/comments/xfn7va/revive_therapeutics_provides_update_on_the/

Also Covid19 and virus DD central on discord is here

https://discord.gg/s8VTSXVC

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.